Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

NCT07033481 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonfluent Variant Primary Progressive Aphasia (nfvPPA)

Interventions

DRUG: Neflamapimod
DRUG: Placebo

Sponsor

EIP Pharma Inc

Collaborators

[object Object]